SCHEMBL200995

SCHEMBL200995

CCNC(C)(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402938 0.77
SCHEMBL1833054 0.75
SCHEMBL12328053 0.71 TSHR (0.30)
SCHEMBL27806552 0.71
SCHEMBL25559928 0.71 TSHR (0.30)
SCHEMBL24793890 0.71 ALDH1A1 (0.32)
Water SCHEMBL27578824 0.69 ALDH1A1 (0.32)
SCHEMBL31292054 0.68
SCHEMBL8950168 0.67
SCHEMBL21377183 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105198794-A Preparation method of alvimopan Hunan huateng pharmaceutical co ltd 2015-12-30 CN claimed
US-12343323-B2 Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof SANTOLECAN PHARMACEUTICALS LLC (US) 2025-07-01 US disclosed
CN-118930474-A Preparation method of key intermediate of ulcerative colitis treatment drug 北京康立生医药技术开发有限公司 2024-11-12 CN disclosed
US-20240358707-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2024-10-31 US disclosed
US-20240317756-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2024-09-26 US disclosed
WO-2023143249-A1 PROTEIN DEGRADATION COMPOUND TARGETING MALT1 上海齐鲁制药研究中心有限公司 2023-08-03 WO disclosed
US-20220213106-A1 Inhibitors of Bruton's Tyrosine Kinase PHARMACYCLICS LLC (US) 2022-07-07 US disclosed
CN-114127134-A Radiopaque polymers 生物相容英国有限公司 2022-03-01 CN disclosed
US-20220008424-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2022-01-13 US disclosed
US-20210228530-A1 TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF SANTOLECAN PHARMACEUTICALS LLC 2021-07-29 US disclosed
US-6100026-A TAGGING MOLECULES DURING CHEMICAL SYNTHESIS BY LINKING EACH MOLECULE TO SUPPORT MATRIX HAVING UNIQUE OPTICALLY-READABLE SYMBOL IMPRINTED ON SURFACE BEFORE, DURING, OR AFTER LINKAGE AND PROGRAMMING REMOTE MEMORY WITH DATA POINT, REPEATING IRORI (US) 2000-08-08 US disclosed
US-6025129-A CONTACTING ONE REACTANT WITH A MATRIX-WITH-MEMORY COMPRISED OF A RECORDING DEVICE ON OR IN A MATRIX WITH LUMINESCENT MOIETIES AND DETECTING OCCURANCE OF THE REACTION; FOR IMMUNOASSAYS, HYBRIDIZATION ASSAYS, RECEPTOR BINDING ASSAYS IRORI (US) 2000-02-15 US disclosed
US-6017496-A ELECTROMAGNETICALLY TAGGED BY PROGRAMMING THE MEMORY WITH DATA CORRESPONDING TO IDENTIFYING INFORMATION OR CAN BE TAGGED BY IMPRINTING THE MATRIX WITH IDENTIFYING INFORMATION; DATA STORAGE; SLEEVE ATTACHED TO A CONTAINER IRORI (US) 2000-01-25 US disclosed
WO-1999062882-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed
US-5961923-A THE MATRIX MATERIALS ARE THOSE THAT ARE USED IN AS SUPPORTS IN SOLID PHASE CHEMICAL AND BIOCHEMICAL SYNTHESES, IMMUNOASSAYS AND HYBRIDIZATION REACTIONS. IRORI (US) 1999-10-05 US disclosed
US-5874214-A USEFUL FOR IDENTIFICATION, TRACKING AND CATEGORIZATION OF COMPONENTS OF COMPLEX MIXTURES OF DIVERSE MOLECULES; DRUG DELIVERY IRORI (US) 1999-02-23 US disclosed
WO-1997049653-A9 SOLID PHASE TYRPHOSTIN LIBRARY LINKED TO MATRICES WITH MEMORIES 1998-04-16 WO disclosed
WO-1997012680-A9 MATRICES WITH MEMORIES, SENSORS WITH MEMORIES AND USES THEREOF 1998-02-26 WO disclosed
WO-1997049653-A2 SOLID PHASE TYRPHOSTIN LIBRARY LINKED TO MATRICES WITH MEMORIES IRORI (US) 1997-12-31 WO disclosed
US-5189042-A Treating autoimmune diseases, preventing transplant rejection MERCK & CO. INC. (US) 1993-02-23 US disclosed